Kanagawa, Japan

Satoshi Inouye

This inventor holds 65 USPTO granted patents and 4 published patent applications, primarily in Luciferase Technology (CPC class G01N). Top assignees: Jnc Corporation, Chisso Corporation, Tokyo Medical and Dental University. Active years: 1991-2022.

USPTO Granted Patents = 65 

% Patents Active = 63.1

Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 344(Granted Patents)

Forward Citations (Not Self Cited) = 323(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Yokohamashi, JP (1991 - 1992)
  • San Diego, CA (US) (1994)
  • Tokyo, JP (1995 - 2013)
  • Yokohama, JP (1992 - 2018)
  • Kanagawa, JP (2008 - 2022)

Company Filing History:


Years Active: 1991-2022

Loading Chart...
Areas of Expertise:
Luciferase
Synthetic Genes
Recombinant Proteins
Calcium-Binding Photoprotein
Coelenterazine
Drug Screening
Mutated Genes
Transcription Activity
Protein Stabilization
Imidazo[1,2-A]Pyrazines
Shrimp Luciferase
Photoprotein
65 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Satoshi Inouye

Introduction: Satoshi Inouye, based in Kanagawa, Japan, is a prominent inventor with a remarkable portfolio of 65 patents. His work primarily focuses on advancements in genetic engineering and biotechnology, significantly contributing to the field with innovative methodologies and novel applications.

Latest Patents: Among Inouye's latest patents is a pioneering method for synthetic genes. This invention outlines a technique for designing optimized genes by selecting preferential codons with high usage frequency in human cells, while ensuring a GC content of no less than 60%. This method sets a general rule for producing proteins with elevated expression levels, facilitating the development of chemically synthesized genes for high-expression capabilities in eukaryotic cells. Another significant patent is for mutated genes for the catalytic protein of luciferase, offering a new luciferase variant distinct from traditional types. This mutation involves specific amino acid substitutions at critical positions, enhancing its functionality and applications.

Career Highlights: Throughout his career, Satoshi Inouye has worked with esteemed organizations, including JNC Corporation and Chisso Corporation. His contributions at these companies reflect his dedication to furthering biotechnological advancements.

Collaborations: Throughout his professional journey, Inouye has collaborated with notable coworkers such as Junichi Sato and Yuiko Sahara. These partnerships have fostered innovative projects and breakthroughs within his field.

Conclusion: Satoshi Inouye's extensive portfolio of patents and his innovative approaches in genetic engineering highlight his exceptional contributions to science and technology. His work continues to inspire advancements that may shape the future of biotechnology and genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…